Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Merck & Co. has entered into an agreement with Janssen Pharmaceuticals, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (J&J), to support the manufacturing and supply of J&J’s COVID-19 vaccine. J&J’s COVID-19...

Amgen has agreed to acquire Five Prime Therapeutics, a South San Francisco, California-based clinical-stage biopharmaceutical company developing immuno-oncology and targeted cancer therapies, for approximately $1.9 billion. Five Prime’s lead...

Biogen has announced plans to build a new gene-therapy manufacturing facility at its Research Triangle Park manufacturing campuses in North Carolina. Through the new facility, Biogen aims to expand its existing operations and combined workforce of...

Perrigo has agreed to sell its generic prescription pharmaceuticals business to Altaris Capital Partners, an investment firm, for $1.55 billion, which includes $1.5 billion in cash. Perrigo first announced plans in 2018 to separate its...

Johnson & Johnson (J&J) has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of J&J, to prevent COVID-19 in...

The US Food and Drug Administration (FDA) has issued guidances and revised previously published guidances for medical product developers, specifically covering vaccines, diagnostics and therapeutics products, to address the emergence and potential...

Merck & Co. has agreed to acquire Pandion Therapeutics, a Watertown, Massachusetts-based company developing therapeutics for autoimmune diseases, for an approximate total equity value of $1.85 billion. Pandion is advancing a pipeline of...